Novartis Ag (NVSEF) Enterprise Value (QoQ) (2009 - 2026)

Novartis Ag (NVSEF) Enterprise Value (QoQ) (2009 - 2026) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn -
10 Novartis Ag - - -

Historic Data

Download Data
DateValue
Mar 31, 2026 113.61%
Dec 31, 2025 -648.58%
Sep 30, 2025 106.09%
Jun 30, 2025 -14,646.81%
Mar 31, 2025 -137.01%
Dec 31, 2024 124.28%
Sep 30, 2024 93.67%
Jun 30, 2024 -10,304.94%
Mar 31, 2024 100.64%
Dec 31, 2023 -15,740.74%
Sep 30, 2023 100.75%
Jun 30, 2023 -13,108.43%
Mar 31, 2023 100.44%
Dec 31, 2022 -11,807.45%
Sep 30, 2022 101.01%
Jun 30, 2022 -9,833.54%
Mar 31, 2022 100.58%
Dec 31, 2021 -3,533.81%
Sep 30, 2021 -4,658.82%
Jun 30, 2021 -86.07%